Showing results (1-10 of 240) with videos related to
Sort By:
Pageof 24
Organic Letters|February 24, 2006
A versatile approach toward the ansamycin antibioticsWeimin Peng, Brian S J BlaggBioorganic & Medicinal Chemistry Letters|December 22, 2022
Recent advances toward the development of Hsp90 C-terminal inhibitorsEva Amatya, Brian S J BlaggOrganic Letters|May 20, 2005
Radester, a novel inhibitor of the Hsp90 protein folding machineryGang Shen, Brian S J BlaggCurrent Medicinal Chemistry|November 11, 2008
Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocketAlison Donnelly, Brian S J BlaggTetrahedron Letters|July 2, 2009
Synthesis of a versatile metacyclophane macrolactamMingwen Wang, Brian S J BlaggAdvances in Experimental Medicine and Biology|April 17, 2020
The Right Tool for the Job: An Overview of Hsp90 InhibitorsJohn Koren, Brian S J BlaggCell Stress & Chaperones|March 9, 2026
The Evolution of Hsp90 C-terminal Inhibitors: From Novobiocin to Potential Clinical CandidatesXiaosheng Jiang, Brian S J BlaggEuropean Journal of Medicinal Chemistry|May 4, 2025
Glucose-regulated protein 94 (Grp94/gp96) in viral pathogenesis: Insights into its role and therapeutic potentialsHao Xu, Brian S J BlaggBioorganic & Medicinal Chemistry Letters|December 14, 2012
Novobiocin analogues with second-generation noviose surrogatesHuiping Zhao, Brian S J BlaggOrganic Letters|October 6, 2006
Synthesis and evaluation of coumermycin A1 analogues that inhibit the Hsp90 protein folding machineryJoseph A Burlison, Brian S J BlaggPageof 24